» Articles » PMID: 19005074

Loss of Gamma-secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis

Abstract

Presenilins (PSs) are components of the gamma-secretase complex that mediates intramembranous cleavage of type I membrane proteins. We show that gamma-secretase is involved in the regulation of cellular lipoprotein uptake. Loss of gamma-secretase function decreased endocytosis of low-density lipoprotein (LDL) receptor. The decreased uptake of lipoproteins led to upregulation of cellular cholesterol biosynthesis by increased expression of CYP51 and enhanced metabolism of lanosterol. Genetic deletion of PS1 or transgenic expression of PS1 mutants that cause early-onset Alzheimer's disease led to accumulation of gamma-secretase substrates and mistargeting of adaptor proteins that regulate endocytosis of the LDL receptor. Consistent with decreased endocytosis of these receptors, PS1 mutant mice have elevated levels of apolipoprotein E in the brain. Thus, these data demonstrate a functional link between two major genetic factors that cause early-onset and late-onset Alzheimer's disease.

Citing Articles

Presenilin Deficiency Results in Cellular Cholesterol Accumulation by Impairment of Protein Glycosylation and NPC1 Function.

Fabiano M, Oikawa N, Kerksiek A, Furukawa J, Yagi H, Kato K Int J Mol Sci. 2024; 25(10.

PMID: 38791456 PMC: 11121565. DOI: 10.3390/ijms25105417.


Lipophorin receptors genetically modulate neurodegeneration caused by reduction of Psn expression in the aging Drosophila brain.

Kang J, Zhang C, Wang Y, Peng J, Berger B, Perrimon N Genetics. 2023; 226(1.

PMID: 37996068 PMC: 10763532. DOI: 10.1093/genetics/iyad202.


Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer's disease.

Essayan-Perez S, Sudhof T Neuron. 2023; 111(20):3176-3194.e7.

PMID: 37543038 PMC: 10592349. DOI: 10.1016/j.neuron.2023.07.005.


: A Model System for Neurological Disorders.

Storey C, Williams R, Fisher P, Annesley S Cells. 2022; 11(3).

PMID: 35159273 PMC: 8833889. DOI: 10.3390/cells11030463.


Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids.

Torres M, Parets S, Fernandez-Diaz J, Beteta-Gobel R, Rodriguez-Lorca R, Roman R Membranes (Basel). 2021; 11(12).

PMID: 34940418 PMC: 8708953. DOI: 10.3390/membranes11120919.


References
1.
Wang R, Tang P, Wang P, Boissy R, Zheng H . Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation. Proc Natl Acad Sci U S A. 2005; 103(2):353-8. PMC: 1326180. DOI: 10.1073/pnas.0509822102. View

2.
Schmidt S, Nixon R, Mathews P . ELISA method for measurement of amyloid-beta levels. Methods Mol Biol. 2005; 299:279-97. DOI: 10.1385/1-59259-874-9:279. View

3.
Mishra S, Watkins S, Traub L . The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery. Proc Natl Acad Sci U S A. 2002; 99(25):16099-104. PMC: 138571. DOI: 10.1073/pnas.252630799. View

4.
Noviello C, Vito P, Lopez P, Abdallah M, DAdamio L . Autosomal recessive hypercholesterolemia protein interacts with and regulates the cell surface level of Alzheimer's amyloid beta precursor protein. J Biol Chem. 2003; 278(34):31843-7. DOI: 10.1074/jbc.M304133200. View

5.
Bales K, Dodart J, DeMattos R, Holtzman D, Paul S . Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv. 2004; 2(6):363-75, 339. DOI: 10.1124/mi.2.6.363. View